QTREX Quantum Ltd.
Business
Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company developing proprietary extracorporeal life support technologies designed to provide respiratory support and oxygenation to critically ill patients. The company's primary product, INSPIRA ART100, has received FDA 510(k) clearance for cardiopulmonary bypass procedures; complementary products include HYLA blood sensor technology for continuous monitoring and VORTX oxygenation technology. The company commercializes these systems globally through distribution partnerships in the United States, Europe, Asia, and emerging markets, with a business model centered on a razor-blade approach leveraging disposables and licensing.
Summary from 20-F filed 2026-03-26
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $289.0K |
| Net income | $-13.22M |
| Total assets | $5.34M |
| Total liabilities | — |
| Stockholders' equity | $2.32M |
| Operating cash flow | $-9.86M |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is QTREX Quantum Ltd.'s CIK number?
QTREX Quantum Ltd.'s SEC CIK number is 0001837493 (1837493). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find QTREX Quantum Ltd.'s SEC filings?
All of QTREX Quantum Ltd.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.